ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,781Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 783

$779K Total Retail Price of All Prescriptions

Rank: 103 out of 783

537 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 537 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 537 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 10,637 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 836 651 1 1
AMLODIPINE BESYLATE 484 461 2 5
SIMVASTATIN 435 347 3 3
LISINOPRIL 359 271 4 4
PRAVASTATIN SODIUM 328 272 5 14
ALENDRONATE SODIUM 308 255 6 25
METFORMIN HCL 267 222 7 8
OMEPRAZOLE 266 234 8 6
SYNTHROID 241 235 9 47
CARVEDILOL 229 212 10 21
LOSARTAN POTASSIUM 228 209 11 18
ATORVASTATIN CALCIUM 212 155 12 11
CITALOPRAM HBR 205 190 13 19
ATENOLOL 202 145 14 17
METOPROLOL SUCCINATE 196 186 15 13
FUROSEMIDE 177 140 16 7
HYDROCHLOROTHIAZIDE 152 146 17 12
TRAMADOL HCL 151 125 18 20
GLIMEPIRIDE 150 128 19 34
DONEPEZIL HCL 146 142 20 24
WARFARIN SODIUM 144 108 21 10
ZOLPIDEM TARTRATE 133 115 22 23
POTASSIUM CHLORIDE 128 109 23 16
METOPROLOL TARTRATE 125 113 24 9
GABAPENTIN 123 103 25 15
CLOPIDOGREL 119 97 26 29
CIPROFLOXACIN HCL 114 101 27 62
SERTRALINE HCL 111 103 28 22
NEXIUM 103 93 29 28
LANTUS 102 72 30 38
FLUOXETINE HCL 100 43 31 45
SPIRIVA 94 69 32 59
MELOXICAM 93 86 33 37
CRESTOR 92 84 34 27
OXYBUTYNIN CHLORIDE 89 87 35 96
NAMENDA 87 87 36 32
AMITRIPTYLINE HCL 86 57 R 37 77
HYDROCODONE-ACETAMINOPHEN 83 51 S3 38 2
PLAVIX 82 69 39 51
ZETIA 81 76 40 80
RANITIDINE HCL 80 50 41 44
DIOVAN 79 67 42 49
KLOR-CON 10 79 78 42 102
CLONIDINE HCL 77 68 44 60
LIPITOR 70 59 45 114
FENOFIBRATE 70 66 45 66
VENLAFAXINE HCL ER 70 40 45 100
KLOR-CON M20 63 58 48 48
ROPINIROLE HCL 63 62 48 74
AZITHROMYCIN 62 51 50 41
PREDNISONE 61 52 51 36
JANUVIA 60 36 52 73
TRICOR 60 49 52 134
HYDRALAZINE HCL 59 59 54 78
TORSEMIDE 56 40 55 126
LANTUS SOLOSTAR 55 44 56 91
SINGULAIR 54 42 57 90
PANTOPRAZOLE SODIUM 53 35 58 30
RISPERIDONE 52 30 59 67
CYMBALTA 52 48 59 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.